NCT05671822 2026-02-12Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric CancerSuzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 2 Recruiting258 enrolled